NEW YORK, Feb. 26, 2016 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Massachusetts on behalf of investors who purchased Imprivata, Inc. (NYSE:IMPR) securities between July 30, 2015 and November 2, 2015.
Click here to learn about the case: http://www.wongesq.com/pslra/imprivata-inc. There is no cost or obligation to you.
The complaint alleges that during the Class Period, defendants made materially false and misleading statements and/or omitted material information concerning demand for the Company’s IT security offerings and its sales trends, thereby inflating the price of Imprivata stock. The complaint further alleges that certain Imprivata executives and insiders took advantage of the inflation by selling more than $72 million worth of personally-held Imprivata stock during this time period.
If you suffered a loss in Imprivata you have until April 4, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/imprivata-inc.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]


ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Winter Storm Devin Triggers Massive Flight Cancellations and Travel Disruptions Across the U.S.
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
FDA Approves Mitapivat for Anemia in Thalassemia Patients
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 



